NewAmsterdam Pharma Company N.V. SEC filings and other documents

Explore the latest company documents and SEC filings from NewAmsterdam Pharma Company N.V., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Cantor Global Healthcare Conference 2025

Sep 4, 2025

Transcript

Citi's Biopharma Back to School Conference

Sep 3, 2025

Transcript

Q2 2025

Aug 6, 2025

Earnings release8-K

Quarterly report10-Q

Status Update

Jul 30, 2025

Slides

Press release

R&D Day 2025

Jun 11, 2025

Slides

Q1 2025

May 8, 2025

Earnings release8-K

Quarterly report10-Q

Guggenheim SMID Cap Biotech Conference

Feb 5, 2025

Transcript

Corporate Presentation

Jan 10, 2025

Slides

2024

Q4 2024

Feb 26, 2025

Earnings release8-K

Annual report10-K

Status Update

Dec 10, 2024

Slides

Press release

Study Update

Nov 20, 2024

Slides

Press release

Investor Presentation

Nov 18, 2024

Slides

Q3 2024

Nov 6, 2024

Quarterly report10-Q

Earnings release8-K

Q2 2024

Aug 7, 2024

Quarterly report10-Q

Earnings release8-K

Study Update

Jul 29, 2024

Slides

Press release

Goldman Sachs 45th Annual Global Healthcare Conference

Jun 10, 2024

Slides

R&D Day

May 16, 2024

Slides

Q1 2024

May 9, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Feb 28, 2024

Earnings release8-K

Annual report10-K

Corporate Presentation

Nov 27, 2023

Slides

Q3 2023

Nov 13, 2023

Earnings release8-K

Q2 2023

Aug 7, 2023

Earnings release8-K

Q1 2023

May 8, 2023

Earnings release8-K

2022

Q4 2022

Mar 31, 2023

Earnings release8-K